Cite
HARVARD Citation
Mohammed, S. et al. (n.d.). 3237 The retinoid derivative drug, acitretin, reduces viability of primary Chronic Lymphocytic Leukemia(CLL) cells from treatment naïve patients and of the MEC-1 cell line but has a variable effect on cell migration. European journal of cancer. pp. S661-. [Online].